Table 3.
Metastasis side | P χ2 test | |||
---|---|---|---|---|
Right (N) | Left (N) | Bilateral (N) | ||
Patient-related variables | ||||
Sex | ||||
Male/female | 11/1 | 9/0 | 15/3 | 0.546 |
Age | ||||
Mean ± SD | 57.7 ± 8.3 | 62.6 ± 9.9 | 61.9 ± 8.7 | 0.349a |
Pack-years | ||||
Mean ± SD | 80.8 ± 20.2 | 84.0 ± 19.6 | 68.6 ± 26.8 | 0.202a |
COPD | ||||
No/yes | 6/6 | 5/4 | 10/8 | 1.000 |
Arterial hypertension | ||||
No/yes | 10/2 | 4/5 | 7/11 | 0.050 |
Coronary disease | ||||
No/yes | 12/0 | 9/0 | 13/5 | 0.054 |
Diabetes mellitus | ||||
No/yes | 11/1 | 9/0 | 14/4 | 0.406 |
Gastritis/ulcer | ||||
No/yes | 12/0 | 7/2 | 17/1 | 0.216 |
Hypothyroidism | ||||
No/yes | 12/0 | 6/3 | 15/3 | 0.063 |
Other comorbidity | ||||
No/yes | 11/1 | 7/2 | 15/3 | 0.740 |
Disease-related variables | ||||
Histotype | ||||
Non-differentiated NSCLC | 6 | 2 | 7 | 0.194 |
Squamous | 2 | 4 | 5 | |
Adenocarcinoma | 3 | 3 | 6 | |
Large cell carcinoma | 1 | 0 | 0 | |
Location | ||||
Central/peripheral | 10/2 | 8/1 | 15/3 | 1.000 |
Diagnosis to brain metastases time (weeks) | ||||
Median (IR) | 18 (4–40) | 0 (0–26) | 14 (0–36) | 0.632b |
Notes: Analysis of variance;
Kruskall–Wallis test.
Abbreviations: COPD, chronic obstructive pulmonary disease; IR, interquartile range; NSCLC, non-small cell lung cancer; SD, standard deviation.